FLGT FY 2020 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

FY 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$422M+1196.5% YoY

Gross Profit

$332M78.7% margin

Operating Income

$290M68.8% margin

Net Income

$214M50.8% margin

EPS (Diluted)

$8.91

Cash Flow

Operating Cash Flow

$141M

Free Cash Flow

$104M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$700M

Total Liabilities

$131M

Stockholders' Equity

$569M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$422M	$33M	+1196.5%
Gross Profit	$332M	$18M	+1701.8%
Operating Income	$290M	-$428,000	+67893.9%
Net Income	$214M	-$411,000	+52243.6%